Bryan Johnson, the trailblazing billionaire who has been actively slowing down his aging process. In a bold move, he publicly acknowledged his use of Metformin through his open-source project, Blueprint.
Originally developed in Europe, Metformin gained legal status in the USA during the 1990s. Its primary purpose was to assist diabetics in managing their blood sugar levels, thereby improving their cardiovascular health and metabolism. However, as trials expanded to include healthy individuals, remarkable discoveries emerged.
Taking Metformin not only reduces the risk of developing cancer, Alzheimer's, and diabetes but also benefits the cardiovascular system. The intriguing aspect is that its effects on aging are not direct but rather indirect, stemming from the profound impact it has on our body's cellular metabolism.
At Longer Living, I have outlined practical steps to harness these remarkable benefits. One key recommendation is to take Metformin in divided doses throughout the day, ranging from 500-2000 mg, with a cautious approach of starting with a lower dosage. For a comprehensive exploration of the study on Metformin, you can access the Full Study here.